Webinar: Scalable strategies for dual production of MSC and their derived EV

Webinar: Scalable strategies for dual production of MSC and their derived EV

 
/upload/pictures-2024-11-11t101310.213-yvhthz.png

Watch the webinar 

We would like to invite you to rewatch our webinar, “Scalable Strategies for Dual Production of MSC and Their Derived Extracellular Vesicles (EVs).” This session will focus on recent advancements in scalable MSC and EV production systems and is intended for professionals in cell therapy and regenerative medicine.

Webinar Topics

Dr. Teresa Mendes from the iBB Group will present a series of approaches developed by her team, addressing:

  • MSC Expansion in Vertical Wheel Reactors – Insights into expanding MSC from various tissue sources.
  • MSC and EV Production with HPL GI EV-Depleted Formulation in Spinner Flasks – A look at formulation optimization for effective production.
  • Manufacturing of MSC and EV in a Controlled Stirred-T

About the Speaker

/upload/pictures-938-x-938-px-15-rdzzsp.jpg    Dr. Teresa Mendes has a PhD in Bioengineering and a background in molecular biology, specializing in 3D disease models and precision medicine. Her current research aims to improve culture systems for cell therapy applications, and she will provide practical insights into scalable MSC and EV production techniques.

 

Watch the webinar 


 

About AventaCell BioMedical Corp.

AventaCell BioMedical Corp. is a leader in human-derived products for cell culture and tissue regeneration, with a focus on serum-free solutions for translational research. The Helios Bioscience product line supports the efficient expansion of various cell types, including MSCs and immunocells, essential for regenerative medicine research.